|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
11/14/2019 |
$109.95 |
$110.53 |
$109.52 |
$110.02 |
4.15M | 11/15/2019 |
$110.23 |
$110.26 |
$109.71 |
$110.02 |
4.34M | 11/18/2019 |
$109.99 |
$110.43 |
$109.10 |
$109.32 |
23.85M | 11/19/2019 |
$109.30 |
$109.69 |
$107.96 |
$108.13 |
32.93M | 11/20/2019 |
$108.01 |
$108.59 |
$107.27 |
$108.24 |
191.22M |
|
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. | |
|
Bristol Myers Squibb (CELG) has the following price history information. Looking back at CELG historical stock prices for the last five trading days, on November 14, 2019, CELG opened at $109.95, traded as high as $110.53 and as low as $109.52, and closed at $110.02. Trading volume was a total of 4.15M shares. On November 15, 2019, CELG opened at $110.23, traded as high as $110.26 and as low as $109.71, and closed at $110.02. Trading volume was a total of 4.34M shares. On November 18, 2019, CELG opened at $109.99, traded as high as $110.43 and as low as $109.10, and closed at $109.32. Trading volume was a total of 23.85M shares. On November 19, 2019, CELG opened at $109.30, traded as high as $109.69 and as low as $107.96, and closed at $108.13. Trading volume was a total of 32.93M shares. On November 20, 2019, CELG opened at $108.01, traded as high as $108.59 and as low as $107.27, and closed at $108.24. Trading volume was a total of 191.22M shares.
CELG Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of CELG, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
11/20/2019 |
|
Start price/share: |
$73.32 |
|
End price/share: |
$108.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
47.63% |
|
Average Annual Total Return: |
7.23% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14,766.34 |
|
Years: |
5.58 |
|
|
|
Date |
Close |
11/14/2019 | $110.02 | 11/15/2019 | $110.02 | 11/18/2019 | $109.32 | 11/19/2019 | $108.13 | 11/20/2019 | $108.24 |
|
|